Literature DB >> 2672691

Oxygen toxicity: an introduction.

C C Bostek.   

Abstract

Although oxygen has been known to be toxic for more than 200 years, the clinical importance of oxygen toxicity was not appreciated until an epidemic of retrolental fibroplasia occurred in the early 1950s. Oxygen at high partial pressures is toxic to the respiratory, cardiovascular, nervous, and gastrointestinal systems. Toxicity results from the formation of oxygen-free radicals. These arise within mitochondria as oxygen is reduced to water, as byproducts of prostaglandin and thromboxane synthesis, and by the xanthine oxidase catalyzed reduction of xanthine or hypoxanthine. They are also produced by activated macrophages as part of the immune response. Superoxide anion is the radical most commonly produced. It dismutes to hydrogen peroxide, which is able to diffuse through lipid membranes. Hydrogen peroxide reacts with transition metals to produce the highly reactive hydroxyl radical which can initiate chain reactions of lipid peroxidation leading to cell rupture. Oxygen radical scavengers such as superoxide dismutase and catalase protect the body against normal levels of oxygen-free radicals. Oxygen toxicity can result from either reperfusion of ischemic tissue or prolonged exposure to high concentrations of oxygen. Limiting hyperoxia to maintain arterial oxygen percent saturation (SaO2) greater than or equal to 90% is recommended.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672691

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  16 in total

Review 1.  Hyperoxia: good or bad for the injured brain?

Authors:  Michael N Diringer
Journal:  Curr Opin Crit Care       Date:  2008-04       Impact factor: 3.687

2.  Change is in the air: dying to breathe oxygen in acute respiratory distress syndrome?

Authors:  Pierce Geoghegan; Sean Keane; Ignacio Martin-Loeches
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

3.  Suppression of oxidative damage by Saccharomyces cerevisiae ATX2, which encodes a manganese-trafficking protein that localizes to Golgi-like vesicles.

Authors:  S J Lin; V C Culotta
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Hyperbaric Oxygen Therapy in the Treatment of Acute Severe Traumatic Brain Injury: A Systematic Review.

Authors:  Samuel Daly; Maxwell Thorpe; Sarah Rockswold; Molly Hubbard; Thomas Bergman; Uzma Samadani; Gaylan Rockswold
Journal:  J Neurotrauma       Date:  2018-01-22       Impact factor: 5.269

5.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

6.  Admission oxygenation and ventilation parameters associated with discharge survival in severe pediatric traumatic brain injury.

Authors:  Vijay Kumar Ramaiah; Deepak Sharma; Li Ma; Sumidtra Prathep; Noah G Hoffman; Monica S Vavilala
Journal:  Childs Nerv Syst       Date:  2012-12-04       Impact factor: 1.475

7.  The requirement for yeast superoxide dismutase is bypassed through mutations in BSD2, a novel metal homeostasis gene.

Authors:  X F Liu; V C Culotta
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  The ATX1 gene of Saccharomyces cerevisiae encodes a small metal homeostasis factor that protects cells against reactive oxygen toxicity.

Authors:  S J Lin; V C Culotta
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  Response of rat lung tissue to short-term hyperoxia: a proteomic approach.

Authors:  Oliver Spelten; Wolfgang A Wetsch; Georg Wrettos; Armin Kalenka; Jochen Hinkelbein
Journal:  Mol Cell Biochem       Date:  2013-08-11       Impact factor: 3.396

10.  Minimum effective concentrations of formalin and sodium percarbonate on the free-living stages of an Australian isolate of Ichthyophthirius multifiliis.

Authors:  James M Forwood; James O Harris; Matt Landos; Marty R Deveney
Journal:  Parasitol Res       Date:  2014-06-20       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.